Menu
  • Welcome
  • Resources
  • Webinars
  • News
  • Stats
  • Forums
  • Team
  • Contact
  • My Account
  • FR
  • Welcome
  • Resources
  • Webinars
  • News
  • Stats
  • Forums
  • Team
  • Contact
  • My Account
  • FR
home/Knowledge Base/Pharmacology

Rationale for the Use of Interferons in New Pandemic

51 views 0 05/06/2020 Valérie Hayes-Martel

Before COVID-19

  1. Interferons are among the earliest cytokines produced during a viral infection2 and generate a cascade that culminates in controlling viral replication and inducing an adaptive immune response.3 
  2. Type 1 interferons (IFN-1) have frequently been studied against coronaviruses, having the most antiviral properties.
    • They can be subdivided in α, β, ε, ω and κ subtypes;
    • They are secreted by various cell types, especially plasmacytoid dendritic cells, upon recognition of viral constituents by pattern recognition receptors (PRRs)2;
    • Once produced, interferons are recognized cells and activate the JAK-STAT pathway. This then leads to the phosphorylation of transcriptional factors STAT1 and STAT2, and together with a third transcription factor, IRF9, they form the Interferon Stimulated Gene Factor 3 (ISGF3) complex. The complex is then relocalized to the nucleus so that it can activate the transcription of interferon stimulated genes (ISG);1,2,3
    • ISGs produce proteins can interfere with viral replication by mechanisms such as slowing of cell metabolism and secretion of cytokines promoting adaptive immunity.2
  3. SARS-CoV-2 is closely similar to MERS-CoV and SARS-CoV coronaviruses, against which IFN-1 treatments have been studied in vitro and in vivo, combined or not with other medications.

    • Though some potential benefit has been demonstrated, a lack of significant improvement was possibly explained by the mechanisms of suppression of the IFN signaling pathway used by SARS-CoV and MERS-CoV.2, 3
      • The Orf6 and Orf3 protein of SARS-CoV plays major role in inhibiting IFN type 1 response, thus decreasing STAT1 phosphorylation2.
      • This delayed IFN type 1 can potentially lead to a pro-inflammatory cytokines response3.

 

During COVID-19 outbreak 

  1. The Orf3 and Orf6 proteins of SARS-CoV-2 are truncated and have therefore potentially lost their anti-IFN function.2
  2. In vitro study showed that SARS-CoV-2 is unable to completely inhibit IFN-1 response compared to SARS-CoV1.
    • Significant reduction in viral replication at 24 and 48 hours was seen
    • Infected cells were capable of inducing STAT1 phosphorylation by 48 hours post-infection;
    • Augmented levels of ISGs were produced.
  3. As opposed to SARS-CoV, SARS-CoV-2 could be more sensitive to recombinant IFN-1α pretreatment in vitro, lacking the capacity to restrain a type 1 interferon response.1-2

 

 

This data comes from a study conducted at the University of Texas Medical Branch in Galveston, Texas, with firstly, VeroE6 cells that were incubated with 1000 units/mL of recombinant type 1 IFN alpha 18 hours prior to infection with SARS-CoV-2 and that were compared with cells free of IFN-1. Secondly, IFN competent Calu3 2B4 cells were infected with SARS-CoV-2. Multiple outcomes were examined for both cell types, such as titers of viral and host proteins, viral replication and ISG expression.

Clinical trials for Interferons are currently underway

Sources:

  1. Lokugamage, K.G., Hage, A., Schindewolf, C., et al (April 9, 2020). SARS-CoV-2 is sensitive to type I interferon pretreatment. bioRxiv. https://doi.org/10.1101/2020.03.07.982264
  2. Sallard, E., Lescure, F., Yazdanpanah, Y., et al (April 7, 2020). Type 1 interferons as a potential treatment against COVID-19. Antiviral Research. https://doi.org/10.1016/j.antiviral.2020.104791
  3. Prompetchara E., Ketloy C., Palaga T. (March 2020). Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. Asian Pacific Journal of Allergy and Immunology. https://doi.org/10.12932/AP-200220-0772

 

Tags:cytokineInterferonIFN-1αin vitroviral replication

Was this helpful?

Yes  No
Related Articles
  • The Use of Corticosteroids in Adrenal Insufficiency
  • Understanding the Role of Vitamin D
  • Is Testosterone a Good or a Bad Guy?
  • Summary of Emerging Treatment Options
  • Transplantation of Mesenchymal Stem Cells in Critically Ill Patients
  • Treatment Options for Pregnant Women
Pharmacology
  • Rationale for the Use of Interferons in New Pandemic
  • The Use of Corticosteroids in Adrenal Insufficiency
  • Understanding the Role of Vitamin D
  • Is Testosterone a Good or a Bad Guy?
  • Summary of Emerging Treatment Options
  • Transplantation of Mesenchymal Stem Cells in Critically Ill Patients
View All 22  
Popular Articles
  • Acute Acro-Ischemic Lesions in Children
  • Insights About Reinfection and Immunization
  • What Is the Efficacy of Masks in Preventing Transmission?
  • Rationale of Old Antimalarial Drugs Against New Pandemic
  • Acral Lesions: What We Know
Specialties
  • Endocrinology
  • Anesthesiology
  • Cardiology
  • Dental Surgery
  • Dermatology
  • Emergency Medicine
  • ENT
  • Geriatrics and Palliative Care
  • Gastroenterology
  • Hematology
  • Infectious Diseases
  • Intensive Care
  • Neurology
  • OB-GYN
  • Oncology
  • Ophthalmology
  • Pediatrics
  • Pharmacology
  • Preventive Medicine
  • Protection of Healthcare Workers
  • Psychiatry
  • Public health
  • Other Internal Medicine Specialties
  • Radiology
  • Respirology
  • Stages of COVID-19 Infection
    • Presumption & Prevention
    • Screening & Diagnosis
    • Mild Infection
    • Moderate Infection
    • Severe Infection
    • Outcomes
  • Surgery
About How I Treat COVID-19

Our website is dedicated to helping healthcare professionals find accurate and up-to-date information about the best ways to manage and treat patients affected by the COVID-19 outbreak.

Navigation
  • Resources
  • News
  • Webinars
  • Forum
Useful Links
  • COVID-19 Protocols
  • Health Canada
  • WHO
  • CDC
Practice

  • Privacy Policy
  • Terms & Conditions
  • How I Treat Covid-19 © 2020 Made with ♥ by Mondien